Rapid Biosystems' Rise: A Cautionary Tale of Growth and Hubris? The latest earnings call from Rapid Micro Biosystems, Inc.
highlights explosive growth and impressive financials, but a closer examination reveals a complex web of strategic shifts and risk factors.
Rapid Micro Biosystems' Q2 2026 earnings call was marked by record consumable revenue and units sold, driven primarily by its growing installed base and increasing system utilization among top pharma customers.